Point-of-care (POC) coagulation analyzers that measure prothrombin time/international normalized ratio (PT/INR) on ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
May 5, 2017 β A study of how policies restricting pharmaceutical promotion to physicians affect medication prescribing ...
May 05, 2017
May 16, 2017 β Here is a list of the late-breaking clinical trials presented at theΒ Heart Rhythm Society (HRS) 2017 ...
May 16, 2017
April 3, 2017 β There is no evidence that adding a new cholesterol-lowering drug to treatment with a statin causes ...
April 03, 2017
March 29, 2017 β Uninterrupted treatment with dabigatran (Pradaxa), a non-vitamin K, novel antagonist oral anticoagulant ...
March 29, 2017
March 29, 2017 β Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good ...
March 29, 2017
News | Chronic Total Occlusion (CTO) | Dave Fornell
March 29, 2017 β In patients with a complete, persistent arterial blockage, medication alone was found to be equal to pe ...
March 29, 2017
March 28, 2017 β When used as a preventive measure during heart surgery, the heart failure drug levosimendan did not ...
March 28, 2017
March 27, 2017 β Using genetic testing to help personalize warfarin therapy given to patients undergoing elective ...
March 27, 2017
March 24, 2017 β Safe implementation of new technologies and therapies accompany classic patient safety challenges on ...
March 24, 2017
March 23, 2017 β Bleeding complications did not increase for patients with acute coronary syndrome treated with ...
March 23, 2017
March 23, 2017 β In patients at elevated risk for a recurrence of potentially life- threatening blood clots, a low dose ...
March 23, 2017
March 22, 2017 β In a clinical program that was terminated early, the experimental PCSK9 inhibitor bococizumab, when ...
March 22, 2017
March 21, 2017 β About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood clots ...
March 21, 2017
March 20, 2017 β The most important late-breaking pharmaceutical trial at the 2017 America College of Cardiology annual ...
March 20, 2017Β© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now